OUREXPERTISE
Laboratoires FILLMED® has designed, developed and marketed anti-ageing products for medical aesthetic professionals since 1978: for surgeons, dermatologists and aesthetic practitioners. These products correct the signs of ageing and improve skin quality.
WHERE IT ALL STARTED
Michel Tordjman, a French aesthetic practitioner with a particular fascination for cellular biology, founded our laboratory in 1978 . He pioneered NCTF®, New Cellular Treatment Factor, a unique, injectable solution that corrects the effects of skin ageing.
Dr Tordjman’s innovations were originally intended to provide dermatologists and aesthetic medicine doctors with an extensive range of treatment solutions: peels, hyaluronic acid injections and mesotherapy.
Dr Michel TORDJMAN
FOUNDER (FILLMED)
TIMELINE
1978
The Laboratories FILLMED were founded by a French doctor of aesthetic medicine. Some years later, he created the unique, injectable solutions NCTF® 135 & NCTF® 135 HA, developed to correct* the signs of skin ageing.
2013
Launch of SKIN PERFUSION, a skincare line specifically formulated to accompany medical aesthetic treatments and protocols.
2009
Launch of X-HA3® dermal filler, a versatile gel of hyaluronic acid with a high purity, allowing the correction of wrinkles and restoration of volumes. This signs the 360° approach to skin rejuvenation with a comprehensive portfolio.
2016
Launch of ART FILLER®, a line of 4 Dermal Fillers formulated with TRI-HYAL® Technology: combining 3 types of hyaluronic acid, giving optimal malleability for HAUTE SCULPTURE treatments.
2011
Beauty specialists provide anti-ageing protocols in their institutes, based on aesthetic procedures such as peels and mesotherapy.
2019
Launch of NanoSoft®, the smallest needle on the market for a near painless injection.
2019
The era of POSITIVE PRO-AGEING
FILLMED® enters the era of POSITIVE PRO-AGEING to address
the concerns of young and more mature patients
2020
with ART FILLER LIPS & ART FILLER LIPS SOFT
LIP MENU Launch
EXPERTINHA
OUR EXPERTISE
Laboratories FILLMED has expertise in hyaluronic acid. A custom-built production unit with latest generation technologies was designed specifically for ART FILLER®.
QUALITY GUARANTEE
In compliance with stringent quality requirements, the factory guarantees a manufacturing process in line with strict international standards: ISO 14644-1 and ISO 13485. All of our syringes are individually inspected, manually and visually assessed, one by one, ensuring maximum quality and security standards.
CONTINUOUS INNOVATION FILLMED
Laboratories invest in its innovative manufacturing, with 20% of the sales revenue being dedicated to R&D every year.
INNOVATIVE RESEARCHES FILLMED
plans the scientific studies thanks to the most updated technologies in order to prove the performance and safety of its products.
IN VITRO STUDIES (BASED ON CELL CULTURES):
We test our products on the primary human skin cells adapted with daily real conditions such as aged fibroblasts obtained from the depth of the wrinkles, skin cells under UV radiation or oxidative stress, in order to insure the clinical effect of the products. The skin cells would be evaluated either for their morphology or their activities/functions.
EX VIVO STUDIES (BASED ON TISSUE):
In order to meet the most adapted laboratory condition to the real human skin, we test our products on the human living skin pieces: this pieces, taken from abdominoplasty or lifting surgeries, could be kept from 24 hours to 3 weeks in the laboratory. After applying the products (topical or injections) we could subsequently evaluate skin samples (biopsies) through all available methods such as classic microscopes, electronic microscopes, dosing the markers, etc.
CLINICAL TRIALS:
We plan the different multicentric, comparative and long term studies with the sufficient sample size to provide the reliable data in order to insure the practitioners and also the patients regarding the safety and the efficacy of FILLMED products. Thanks to these studies, we could propose also the most precise protocols to physicians.
WHATWOMENWANT
Aesthetic medicine is becoming more and more accessible (in 2017 global growth exceeded 8%). According to a study* 62% of French women currently think that aesthetic medicine is a way of improving individuals’ well being and how they view ageing. Fewer than 1 in 10 women say they have had an aesthetic medicine treatment but 25% of them are planning to do so at some point. It is clear that how it is viewed is rapidly changing.
Currently, 82% of aesthetic medicine treatments carried out are non-invasive. Injection treatments are proving to be the most popular solution and women are starting to have them earlier and earlier. Worldwide, treatment with hyaluronic acid is the second most widely used technique.
Through the Art Reflexion Therapy survey**, Laboratoires FILLMED demonstrates that ART FILLER® injections go beyond aesthetic enhancement, having a positive psychological impact on patients self-esteem.
Indeed 73% patients reported feeling that their self-image had improved, 64% mentioned feeling more confident and 55% felt more dynamic. A large proportion of patients also felt that their professional image and working relationships had improved. A majority reported enhanced facial appearance and skin quality, reflected in them noticing a refreshed look and being more photogenic.
On average, patients looked 2 to 3 years younger than their actual age, following treatment.
March 2016 Filorga Survey of 1000 women in France. **934 people interviewed in Europe in 2017 by their physicians post injection of at least one of the Laboratoires FILLMED ART FILLER® Products according to the Rosenberg self esteem questionnaire
Positive pro-ageing